Search results contain no confirmation or reports of Thermo Fisher Scientific selling its microbiology business for $1 billion to a European private equity firm.
Available results discuss Thermo Fisher's past acquisitions, such as Novasep’s viral vector manufacturing business for ~$880 million1 and Mesa Biotech1, but no divestitures matching the query.
Other mentions include older sales like Anatomical Pathology in 20192 and acquisitions by Thermo Fisher, but nothing recent or relevant to microbiology divestiture.
Documents are dated up to December 202435, predating 2026, with no matching news.
Sources:
1. https://owlfund.squarespace.com/s/Thermo-Fisher-Scientific-Inc-TMO_Initiating-Coverage-Report-03-Mar-2021.pdf
2. https://paddlefish-copper-lpza.squarespace.com/s/TMO-Thermo-Fisher-Scientific-Pitch-Final-Presentation-vf.pdf
3. https://www.sec.gov/Archives/edgar/data/10795/000001079524000096/bdx-20241219.htm
5. https://investors.bd.com/sec-filings/all-sec-filings/content/0000010795-24-000096/bdx-20241219.htm